Our findings lead us to speculate that in Ph+ cells under hypoxic conditions, the mTORC2-mediated Akt-dependent signaling might contribute to sustain the stemness features; thus, it represents as a potential target option for eradicating CML LSCs. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.